Abstract
ABSTRACT Introduction: Over 1 billion smokers worldwide, one-third of whom have mental and behavioral disorders, exist. However, factors influencing mental and behavioral disorders due to use of tobacco remain unexplored. We aim to investigate the relationship between dietary iron intake and mental and behavioral disorders due to use of tobacco. Methods: Using large population cohort data from the UK Biobank, we employed logistic and Cox regression to explore the cross-sectional and longitudinal associations between dietary iron intake and mental and behavioral disorders due to use of tobacco. Additionally, we assessed the nonlinear relationship between dietary iron intake and mental and behavioral disorders due to use of tobacco using restricted cubic spline plots. Results: The cross-sectional analysis included 50,991 participants. The logistic regression results indicated that dietary iron intake was negatively associated with mental and behavioral disorders due to use of tobacco. A total of 50,921 participants were included in the cohort study. The Cox regression results supported the protective effect of increased dietary iron intake against mental and behavioral disorders due to use of tobacco. The stratified and sensitivity analysis results were consistent with the main results. The restricted cubic spline plots showed a nonlinear relationship between dietary iron intake and mental and behavioral disorders due to use of tobacco. The risk reduction rate initially accelerated and then slowed in the total sample, the two age, and the male groups. In contrast, it declined rapidly at first and then leveled off in the female group. Conclusion: This study found that dietary iron intake has a protective effect against mental and behavioral disorders due to use of tobacco, revealing a nonlinear association between the two. These findings offer valuable insights for the prevention and treatment of mental and behavioral disorders due to use of tobacco in the future.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The data supporting the findings of this study are publicly available at UK Biobank (https://www.ukbiobank.ac.uk).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
The data supporting the findings of this study are publicly available at UK Biobank (https://www.ukbiobank.ac.uk). All data produced in the present study are available upon reasonable request to the authors
